(Q42876181)

English

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer.

scientific article published on 25 September 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

title

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

author name string

Laurent Claret

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

Jian-Feng Lu

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

Yu-Nien Sun

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

publication date

25 September 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

volume

66

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

page(s)

1141-1149

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20872147

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872147%20AND%20SRC:MED&resulttype=core&format=json

retrieved

14 February 2020

exact match

https://scigraph.springernature.com/pub.10.1007/s00280-010-1449-z

0 references

(Q42876181)

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)